Dova Pharmaceuticals, Inc. (NasdaqGM:DOVA) seeks acquisitions. Dova Pharmaceuticals intends to use the proceeds from its securities offering of $300 million to invest in or acquire businesses or technologies that it believes are complementary to its own.